Table 3.
Distributions of clinical and tumor characteristics in 371 endometrial carcinomas by Intraluminal Tumor Cell absence and 2 groups of tubal involvement
| Characteristics, n (%)a | ILTCs | |||
|---|---|---|---|---|
| Absent n=315 (row%) |
Floating ILTCsb n=26 (row%) |
Mucosal ILTCsc n=30 (row%) |
p-valued | |
| Age | 0.37 | |||
| <55 | 49 (89.1) | 4 (7.3) | 2 (3.6) | |
| 55–64 | 112 (82.4) | 13 (9.6) | 11 (8.1) | |
| ≥65 | 154 (85.6) | 9 (5.0) | 17 (9.4) | |
| BMI (kg/m2)e | 0.18 | |||
| Normal weight (<25) | 72 (85.7) | 5 (6.0) | 7 (8.3) | |
| Overweight (25–29.9) | 60 (76.9) | 6 (7.7) | 12 (15.4) | |
| Obese (≥30) | 150 (88.2) | 11 (6.5) | 9 (5.3) | |
| Surgery | 0.16 | |||
| Abdominal H | 237 (85.6) | 25 (9.0) | 15 (5.4) | |
| LAVH | 64 (84.2) | 3 (4.0) | 9 (11.8) | |
| Vaginal H | 6 (66.7) | 2 (22.2) | 1 (11.1) | |
| TLH | 8 (88.9) | 0 (0.0) | 1 (11.1) | |
| Peritoneal cytology f | 0.004 | |||
| None | 284 (85.0) | 29 (8.7) | 21 (6.3) | |
| Negative for malignancy | 26 (89.7) | 1 (3.4) | 2 (6.9) | |
| Positive for malignancy | 4 (57.1) | 0 (0.0) | 3 (42.9) | |
| FIGO Stage | <0.0001 | |||
| 1 | 216 (93.5) | 11 (4.8) | 4 (1.7) | |
| 2 | 15 (79.0) | 4 (21.1) | 0 (0.0) | |
| 3 | 63 (75.9) | 6 (7.2) | 14 (16.9) | |
| 4 | 21 (55.3) | 5 (13.2) | 12 (31.6) | |
| Myometrial invasion | 0.02 | |||
| Less than half | 176 (89.3) | 12 (6.1) | 9 (4.6) | |
| Half or more | 139 (79.9) | 14 (8.1) | 21 (12.1) | |
| LVSI | 0.002 | |||
| Absent | 184 (90.2) | 12 (5.9) | 8 (3.9) | |
| Present | 131 (78.4) | 14 (8.4) | 22 (13.2) | |
| Histotype | 0.02 | |||
| Low-grade endometrioid | 132 (90.4) | 9 (6.2) | 5 (3.4) | |
| High-grade endometrioid | 65 (86.7) | 6 (8.0) | 4 (5.3) | |
| Serous | 52 (71.2) | 8 (11.0) | 13 (17.8) | |
| Carcinosarcoma | 29 (85.3) | 1 (2.9) | 4 (11.8) | |
| Clear cell | 19 (95.0) | 1 (5.0) | 0 (0.0) | |
| Mixed epithelial | 16 (80.0) | 1 (5.0) | 3 (15.0) | |
| Undifferentiated | 2 (66.7) | 0 (0.0) | 1 (33.3) | |
| Radiation | 0.81 | |||
| None | 259 (84.6) | 21 (6.9) | 26 (8.5) | |
| Any | 56 (86.2) | 5 (7.7) | 4 (6.2) | |
| Chemotherapy | <0.0001 | |||
| None | 202 (92.7) | 12 (5.5) | 4 (1.8) | |
| Any | 113 (73.9) | 14 (9.2) | 26 (17.0) | |
Abbreviations and symbols: ILTCs=intraluminal tumor cells,,BMIe=body mass index and data missing for n=39 cases, H=hysterectomy, LAVH=laparoscopic assisted vaginal hysterectomy, TLH=total laparoscopic hysterectomy, LVSI=lymph-vascular space involvement, Peritoneal cytologyf=data missing for n=1case,
a
Row percentages,
b
Floating ILTCS; Floating in the lumen of the fallopian tube and without mucosal attachment,
c
Mucosal ILTCs: Attached to the mucosa of the fallopian tube and with or without floating ILTCs,
d
Chi-square p-value